127
351–357
intensified
issue
email
potentiate
99kg
categorical
delivered
taken
recruitment
463
measurement
458
451
potentially
454
rigid
participant
abnormalitie
medicine
title
shown
copyrighted
still
objective
corbould
phase
cardiometabolic
contribute
378
325
reduce
neither
knudsen
350
insight
studied
exercise
wild
04mg
211
153
alternated
average
337
101
340
311
assessing
skov
gynaecology
389
activity
seen
obstetric
future
sample
presence
only
studies12
setting
236
218
endocrinopathy
subclinical
correlation
wale
type
285
234
check
fatigue
denmark
160
supported
indirect
there
component
LDL
monash
explored
NK
391
infertility
288
193
park
119
rate
180
categorie
410
246
importance
strong
430
447
sensitivity
415
discontinued
189
≥25
into
seven
438
107
outcome
444
preferably
glintborg
journal
ratio
dependent
221
417
allowing
systematic
holtain
260
MBBS1
advertisement
novo
MS
max
marked
state
136
116
retinol
144
disclose
violation
restored
blackwell
661
reducing
show
381
150mg
chicago
308
york
177
001
workload
associated
373
direct
even
ltd
contact
affecting
205
ovarie
obesity
should
highlight
301
instructed
nigel
yellowspring
2†‡
involve
meyer
456
blood
calculated
los
involving
increasing
restriction
cheryce
conversely
predominantly
misso
feasible
2349
366
hickey
due
272
regression
400
percentage
collected
151
GLUT
increased
468
worsen
BP
FAI
287
475
independent
413
294
349
already
clinical
paper
hypocaloric
knowledge
138
last
inserted
carmina
137
food
index
432
intensity
update
exchange
hip
diamanti
inherently
≥100
similar
modalitie
00kg
approximately
reproductive
RA
110
13430
333
circle
pathophysiological
toward
value
oral
finding
323
112
191
rastogi
word
additional
differing
187
described
teede
446
indicate
homeostatic
same
modality
262
vivo
212
lateral
science
free
aimed
correspondence
moran
mmol
reporting
progressive
proces
VO2
5416
positively
lipid
nothing
underpinning
170
hour
potentiating
table
vo2max
227
255
264
line
359
182
hutchison
younger
108
oxidative
232
477
some
671
result
here
function
225
committee
330
207
142
167
360
jogging
text
campu
MD
wa
set
real
hrmax
clayton
raised
biochemical
E399
improvement
1174
clarify
393
expressed
449
non
treadmill
given
274
ensure
ceased
yet
need
aged
white
353
375
expression
could
inversely
128
analysi
303
suggesting
250
per
performed
interval
278
mcgrath
155
130
387
BOX
interaction
research
young
feasibility
aetiological
461
≤30
powered
ability
adherence
physical
257
diagnosi
improve
between
TBF310
425
symptom
Q1
metabolism
sensitive
difficult
indicated
276
volitional
both
disorder4
102
program
power
clin
offered
telephone
although
period
259
424
important
163
hba1c
395
prior
175
stimulated
comparison
steady
347
all
665
endocrinol
adjustment
434
speed
overweight
regular
442
meneilly
vigorou
tanita
2006
pittsburgh
technologie
les
thought
trial
would
198
320
persisted
comprehensively
BMI
IV
2010
significantly
465
361
249
202
total
184
intense
894
publication
infused
140
limitation
manifestation
women
www
412
add
181
385
adequate
healthy
307
therapie
factor
154
controlled
public
control
including
479
global
326
extrinsic
1165
mmhg
fully
335
recommendation
emphasise
kph
profound
HDL
modular
240
440
pathology
ovarian
230
disease
299
115
377
HR
bagsvaerd
lowered
black
lower
univariate
boston
E1054
behind
mitochondrial
must
structured
body
design
androgen
467
metabolic
474
html
clamped
214
8001
studie
WC
buckley
NHMRC
during
using
229
approach
american
RER
lobo
315
14428
gap
absence
338
222
recently
305
involved
ed
544
other
advisory
infusion
217
significance
328
239
122
age
signalling
term
281
269
158
investigator
363
metab
except
E1047
university
polycystic
95T
higher
472
317
firstly
132
compare
literature
cholesterol
NIH
ANOVA
key
target
defronzo
125
mellitu
pill
lost
2008
ranging
cardiovascular
entered
313
appear
significant
written
area
limited
unable
thomson
depicted
397
completed
versu
peripheral
zawadaki
andre
inclusion
height
scholar
within
highlighting
459
demonstrating
284
sport
4†‡
247
impaired
extrinsically
289
165
post
401
186
XQ
147
induced
genetic
319
secretion
worse
≤34
404
2004
OCP
definition
344
confounder
stepto
well
209
progressed
2982
357
preventing
systolic
recent
117
condition
chemistry
morbid
aiming
potential
rational
455
australia
HJ
336
individual
WHO
457
who
383
297
diarie
phd
walking
contributing
previously
attended
plasma
level
051
resistant
cycle
achievable
biodex
affirm
pool
419
290
149
occurring
suggest
210
nutrition
406
173
tobin
365
470
segal
smoking
elucidated
indicating
matched
252
283
expected
156
Q4
supervised
main
421
calculation
classification
papavassiliou
271
basic
world
pre
quantifying
federation
confirm
marker
intensitie
219
2300
advice
105
equal
390
111
protein
408
196
242
945
translocation
additionally
443
date
118
206
many
358
331
martin
2800
life
437
subject
194
220
weight14
used
figure
intrinsic
system
month
1989
author
analyser
nor
VO
examined
ongoing
when
initiated
anthropometric
every
226
derived
contra
431
382
contraceptive
supporting
recovery
model
139
129
national
http
STAT
diastolic
willson
plu
418
menstrual
may
addition
168
135
348
explore
different
145
178
transporter
kandaraki
risk
124
worsened
encoded
care
PO
hyperinsulinaemic
exclusion
intrinsically
388
364
novel
367
software
1992
IFG
fast
highly
E48
2265
similarly
physiology
460
453
324
patient
PA
244
measured
further
benefit
351
presented
study
adequately
arm
change
379
contrasting
southern
113
152
T2DM
number
underpin
452
342
covariate
295
341
case
IR
composition
683
melbourne
organization
institute
intake
comparative
acknowledgment
alone
catheter
actrapid
312
405
combination
surface
237
test
370
produce
309
beneficial
QUICKI
HOMA
lean
cuff
statu
416
380
100
300
physiol
120
286
defined
392
254
1365
comprehensive
best
lifestyle
therefore
endocrinology
399
included
together
investigate
235
50mg
436
adjusted
increase
213
capacity
point
265
296
hand
phenotype
SK
171
pressure
normal
386
dysfunction
technical
referenced
445
previou
200
providing
required
wise
9919
329
also
doi
2012
compliance
161
2001
related
109
consultation
douen
improved
diagnostic
but
membrane
small
over
frank
441
found
briefly
squared
association
exercised
275
induce
helena
85mmhg
197
improving
dietary
UK
responsivenes
statistical
346
427
1111
repeated
noake
active
6x5
biological
gave
glucose
224
accounting
impact
nordisk
managing
ovary
especially
include
ha
30kg
training
achieved
≤25
run
352
evidence
periodically
126
glycated
426
251
under
369
279
176
through
while
modification
256
372
fluctuation
paul
insulin
prevalence
distance
molecular
428
95
gene
clear
our
triangle
distinct
500
based
2kg
moore
independently
screening
preventative
minute
462
414
MOXUS
linear
added
263
394
606553
group
clamp
school
accessed
revealed
476
mechanistic
harrison
haile
exacerbate
fasting
prescription
unit
CL
293
322
469
5716
medical
nuclear
utilised
alleviate
310
192
completion
end
treatment
215
greater
150
window
245
267
persistent
354
current
long
diabete
YSI
inherent
332
than
without
IGT
june
measure
present
repetition
effective
phd3
monitored
footscray
department
intervention
see
pregnancy
diet
assessed
category
central
233
7kg
wherever
368
adjusting
316
88cm
living
time
youngren
maintain
evaluate
208
strength
fax
292
acros
ramlal
291
374
114
common
199
lombard
429
health
detect
1979
resistance
409
hyperandrogenism
consent
hirsutism
human
review
comparable
241
SEM
underlying
feature
baseline
327
practice
heartfoundation
following
mas
correct
280
273
471
data
jean
serie
maximal
hart
haseltine
stable
104
mechanism
general
modifiable
scientific
131
fitnes
complex
314
described14
council
after
13427
disturbance
355
discussion
159
heart
victoria
E392
gradient
1427
quantitative
AEI
assisted
showed
international
illnes
270
195
2005
moderate
sedentary
2007
fertility
2355
signaling
162
433
defect
dorsal
out
334
second
stadiometer
difference
pathway
receptor
thereafter
103
201
423
sterility
insensitive
266
testosterone
size
responsive
reported
4891
furthermore
174
422
follicular
2mg
randomised
assessment
motorised
work
instrument
lactate
recruited
statistic
302
cros
merriam
circumference
5711
skeletal
assist
3380
JD
188
useful
402
whole
tolerance
new
04160
conducted
mitogenic
org
obese
eldho
tailed
medication
whether
ethic
grant
completely
three
respectively
143
needed
464
short
gold
use
2977
2011
recruitable
specifically
publishing
min
week
despite
183
inaccurate
SPSS
439
362
prospective
until
411
169
478
398
384
aerobic
conclusion
two
407
376
majority
1432
count
each
190
298
RTM
3373
drawing
231
243
551
controlling
148
343
variable
therapy
technique
106
dunaif
157
glycaemia
PCOS
203
it
asses
261
japan
321
haemoglobin
profile
371
protocol
resulted
204
1990
435
altering
march
weight
impacted
criteria
triglyceride
ultimately
339
228
intracellular
fellow
268
345
172
223
observed
progression
282
noted
420
126mg
121
≥35
interestingly
available
238
premenopausal
complication
253
mean
448
via
approved
216
however
reproduction
≥30
syndrome
binding
not
meta
kim
samantha
session
179
acquired
beat
overnight
compared
characteristic
foundation
277
activation
edu
epidemic
muscle
one
trend
remain
did
relationship
dyslipidemia
inc
drop
respiratory
informed
uptake
method
133
123
304
severe
effect
euglycaemic
reduced
any
E214
396
258
site
remained
more
lee
futterweit
year
standard
phd1
306
community
166
pair
141
before
403
466
134
report
450
abstract
dockerty
WHR
detailed
primary
correlated
high
demonstrate
sequentially
above
USA
demonstrated
318
473
tokyo
had
exploration
first
resolving
185
waist
248
146
overall
356
sub
164
bivariate
2003